ElizabethA.ClarkMD

PubMed

• Design and validation of a dynamic cell-culture system for bone biology research and exogenous tissue-engineering applications.
  Allori, A. C.,Davidson, E. H.,Reformat, D. D.,Sailon, A. M.,Freeman, J.,Vaughan, A.,Wootton, D.,Clark, E.,Ricci, J. L.,Warren, S. M.> ;J Tissue Eng Regen Med. 2013 Sep 11
• 18 citations
  Bony engineering using time-release porous scaffolds to provide sustained growth factor delivery.
  Caroline Szpalski, Phuong D. Nguyen, Cornelia Vasiliu, Ioana Chesnoiu-Matei, Elizabeth Clark, James E. Smay, Stephen M. Warren> ;The Journal of Craniofacial Surgery. 2012 May 1
• Molecular recognition of chymotrypsin by the serine protease inhibitor ecotin from Yersinia pestis.
  Clark, E.A., Walker, N., Ford, D.C., Cooper, I.A., Oyston, P.F., Acharya, K.R.> ;J Biol Chem. 2011 Jul 8
• The moderating effect of obesity on cognitive-behavioral pain treatment outcomes.
  Sellinger, J.J., Clark, E.A., Shulman, M., Rosenberger, P.H., Heapy, A.A., Kerns, R.D.> ;Pain Med. 2010 Sep
• The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease.
  McDermott MM, Ferrucci L, Guralnik JM, Dyer AR, Liu K, Pearce WH, Clark E, Liao Y, Criqui MH> ;Vasc Med. 2010-08-01
• Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi.
  Upadhyay, A., Burman, J.D., Clark, E.A., Leung, E., Isenman, D.E., van den Elsen, J.H., Bagby, S.> ;J Biol Chem. 2008 Aug 8
• Effect of water storage time and composite cement thickness on fatigue of a glass-ceramic trilayer system.
  Silva, N.A., de Souza, G.M., Coelho, P.G., Stappert, C.J., Clark, E.A., Rekow, E.D., Thompson, V.P.> ;J Biomed Mater Res B Appl Biomater. 2008 Jan
• Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.
  McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, Pearce WH, Schneider JR, Ferrucci L, Celic L, Taylor LM, Vonesh E, Martin GJ, Clark E> ;JAMA. 2004-07-28
• Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease.
  McDermott MM, Greenland P, Guralnik JM, Ferrucci L, Green D, Liu K, Criqui MH, Schneider JR, Chan C, Ridker P, Pearce WH, Martin G, Clark E, Taylor L> ;Vasc Med. 2004-05-01
• The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study.
  McDermott MM, Greenland P, Liu K, Guralnik JM, Celic L, Criqui MH, Chan C, Martin GJ, Schneider J, Pearce WH, Taylor LM, Clark E> ;Ann. Intern. Med.. 2002-06-18
• Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenti...
  Richter G, Hayden-Ledbetter M, Irgang M, Ledbetter JA, Westermann J, Körner I, Daemen K, Clark EA, Aicher A, Pezzutto A> ;J. Biol. Chem.. 2001-12-07
• CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1.
  Otipoby KL, Draves KE, Clark EA> ;J. Biol. Chem.. 2001-11-23
• Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.
  McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ> ;JAMA. 2001-10-03
• B cells with the guts to switch.
  Clark EA, Otipoby KL> ;Nat. Immunol.. 2001-07-01
• CD95/Fas induces cleavage of the GrpL/Gads adaptor and desensitization of antigen receptor signaling.
  Yankee TM, Draves KE, Ewings MK, Clark EA, Graves JD> ;Proc. Natl. Acad. Sci. U.S.A.. 2001-06-05
• Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis.
  Graves JD, Draves KE, Gotoh Y, Krebs EG, Clark EA> ;J. Biol. Chem.. 2001-05-04
• Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells.
  Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, Giachelli CM> ;J. Biol. Chem.. 2000-07-14
• Characterization of human inducible costimulator ligand expression and function.
  Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D, Buckwalter S, Ledbetter JA, Clark EA> ;J. Immunol.. 2000-05-01
• The CD40-inducible Bcl-2 family member A1 protects B cells from antigen receptor-mediated apoptosis.
  Craxton A, Chuang PI, Shu G, Harlan JM, Clark EA> ;Cell. Immunol.. 2000-02-25
• Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.
  Aicher A, Shu GL, Magaletti D, Mulvania T, Pezzutto A, Craxton A, Clark EA> ;J. Immunol.. 1999-12-01
• Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.
  Craxton A, Jiang A, Kurosaki T, Clark EA> ;J. Biol. Chem.. 1999-10-22
• CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.
  Mikhalap SV, Shlapatska LM, Berdova AG, Law CL, Clark EA, Sidorenko SP> ;J. Immunol.. 1999-05-15
• GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation.
  Law CL, Ewings MK, Chaudhary PM, Solow SA, Yun TJ, Marshall AJ, Hood L, Clark EA> ;J. Exp. Med.. 1999-04-19
• Signal transduction pathways that regulate the fate of B lymphocytes.
  Craxton A, Otipoby KL, Jiang A, Clark EA> ;Adv. Immunol.. 1999-01-01
• Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.
  Lupher ML, Rao N, Lill NL, Andoniou CE, Miyake S, Clark EA, Druker B, Band H> ;J. Biol. Chem.. 1998-12-25
• Join now to see all